| Source publication date | |
|---|---|
| Reported on Testosterone Science | |
| Outlet type | Mainstream news |
| Population | Men |
| Source | HealthDay |
| URL | healthday.com/health-news/men-health/high-testosterone-increases-risk-of-heart-rhythm-disorder-review-finds (opens in a new tab) |
Specific claim evaluated
High testosterone increases the risk of atrial fibrillation (headline), and both low and high testosterone levels increased the risk.
Primary research supporting or contradicting the claim
The source is a narrative review that found heterogeneous results, including a pooled analysis of 106 randomized trials without a significant atrial fibrillation signal, and proposed a U-shaped association (Maligireddy et al., 2026). TRAVERSE reported a higher incidence of atrial fibrillation with testosterone gel (Lincoff et al., 2023).
Corrected evidence-based interpretation
Observational data suggest that both low and high testosterone are associated with atrial fibrillation; 1 large randomized trial showed a higher incidence with testosterone therapy, while pooled trial data did not. Causation has not been established, and the 350 to 550 ng/dL target has not been validated.
Rationale for grade
The body of the article reports the review's recommendations reasonably. The headline and key takeaways state a causal effect ('increases risk') that the review authors did not claim and that the mixed evidence does not support. The target range is also reported with a unit error ('dg/dL'). Headline framing is what most readers retain, so the causal claim is the principal finding of this review.
References
- Lincoff AM, Bhasin S, Flevaris P, Mitchell LM, Basaria S, Boden WE, Cunningham GR, Granger CB, Khera M, Thompson IM, et al. Cardiovascular safety of testosterone-replacement therapy. N Engl J Med. 2023;389(2):107-117. PMID
Supporting excerpt: "noninferior to placebo with respect to the incidence of major adverse cardiac events" - Maligireddy AR, Barua ST, Barua RS. Association of testosterone and testosterone replacement therapy with atrial fibrillation: an updated review. J Endocr Soc. 2026;10(9):bvag180. PMID
Supporting excerpt: "Converging evidence thus supports a U-shaped T-AF relationship."